Search
for
Sort by
Research 151–180 of 1000+
- Hypertension and aldosterone levels in women with early-onset androgenetic alopecia
- 5α-Reductases In Human Physiology: an Unfolding Story
- Ursolic acid reduces prostate size and dihydrotestosterone level in a rat model of benign prostatic hyperplasia
- Cinnamomi Cortex (Cinnamomum verum) Suppresses Testosterone-induced Benign Prostatic Hyperplasia by Regulating 5α-reductase
- Effect of finasteride and/or terazosin on serum PSA: Results of VA cooperative study #359
- Finasteride
- Doping-Control Analysis of the 5α-Reductase Inhibitor Finasteride: Determination of Its Influence on Urinary Steroid Profiles and Detection of Its Major Urinary Metabolite
- Antiandrogens: Clinical applications
- 5-Alpha reductase deficiency
- Dutasteride: a review of current data on a novel dual inhibitor of 5alpha reductase.
- Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia
- Side Effects of 5‐Alpha Reductase Inhibitors: A Comprehensive Review
- Ejaculations and Benign Prostatic Hyperplasia: An Impossible Compromise? A Comprehensive Review
- Maximum Efficacy of Finasteride Is Obtained within 6 Months and Maintained over 6 Years
- Finasteride-its impact on sexual function and prostate cancer
- Patients with a large prostate show a higher prevalence of androgenetic alopecia
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- Prevalence of metabolic syndrome and its components among men with and without clinical benign prostatic hyperplasia: a large, cross-sectional, UK epidemiological study
- The Effect of 5 -Reductase Inhibitors on Erectile Function
- Clinical relevance of testosterone and dihydrotestosterone metabolism in women
- Risk of erectile dysfunction associated with use of 5-α reductase inhibitors for benign prostatic hyperplasia or alopecia: population based studies using the Clinical Practice Research Datalink
- Trichoscopic findings of androgenetic alopecia and their association with disease severity
- Baldness, benign prostate hyperplasia, prostate cancer and androgen levels
- Improvement in androgenetic alopecia in 53-76-year-old men using oral finasteride
- Oral ivermectin in the treatment of scabies
- Immunofluorescence analysis of the basement membrane zone components in human anagen hair follicles
- Does a male polycystic ovarian syndrome equivalent exist?
- Long-term use of 5α-reductase inhibitors and the risk of male breast cancer
- Androgenetic alopecia as an early marker of benign prostatic hyperplasia
- Risks and side effects in the medical management of benign prostatic hyperplasia